|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating expenses: | |||||
| Selling, general and administrative | |||||
| General and administrative | |||||
| Research and development | |||||
| Loss from operations | |||||
| Other income (expense): | |||||
| Change in fair value of warrant liabilities | |||||
| Realized foreign currency translation loss from dissolution of subsidiaries | |||||
| Foreign currency gain | |||||
| Other income | |||||
| Change in fair value of derivative warrant liability | |||||
| Interest and dividends, net | |||||
| Other income, net | |||||
| Loss before income taxes | |||||
| Net loss from discontinued operations, net of tax | |||||
| Net loss | |||||
| Foreign currency translation | |||||
| Comprehensive loss | |||||
| Weighted-average common shares outstanding, basic (in Shares) | |||||
| Weighted-average common shares outstanding, diluted (in Shares) | |||||
| Basic loss per share from continuing operations (in Dollars per share) | |||||
| Basic loss per share from discontinuing operations (in Dollars per share) | |||||
| Basic loss per share (in Dollars per share) | |||||
| Diluted loss per share (in Dollars per share) | |||||
Loading...